Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Europe EU Italy

Another Italian Notified Body Designated Under MDR

  • News

Executive Summary

This new listing is the tenth Italian notified body under the Medical Device Regulation, bringing the total number of notified bodies to 36.

You may also be interested in...



German Notified Body Latest To Be Designated Under MDR

The latest notified body to be listed under the EU Medical Device Regulation brings the total number to 37.

European Commission Proposal To Free Up Notified Body Time And Extend Reassessment Deadlines

The EU is in urgent need of more notified bodies to test medtech products under the Medical Device and IVD Regulations. The commission is taking steps to free up everyone’s time.

EU Designates First Czech Notified Body Under MDR

The latest notified body listing brings total number of EU designated Medical Device Regulation testing and certification organizations to 35.

Table

View full table

Topics

Tags:
Europe EU Italy
Latest Headlines

German-Speaking European Associations Collaborate To Focus On Medtech’s Needs

US FDA Chief Scientist Bumpus Will Become Principal Deputy Commissioner

News We’re Watching: Biden Moves To Strengthen Supply Chain; More Medtech-Related Prosecutions; $5.5M Sepsis Grant For Siemens

FDA Receives Thousands Of Opinions On Proposal To Regulate LDTs As Comment Period Comes To A Close

See All
UsernamePublicRestriction

Register

MT147418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By